Journal
FRONTIERS IN IMMUNOLOGY
Volume 12, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2021.680648
Keywords
acute kidney injury; mitochondrial DNA; STING; TLR9; NLRP3
Categories
Funding
- National Natural Science Foundation of China [81873599, 81970581, 82070701]
- Nanjing Medical Science and Technique Development Foundation [QRX17166]
Ask authors/readers for more resources
Mitochondrial dysfunction plays a critical role in the occurrence and progression of acute kidney injury (AKI). Damaged mitochondria release mtDNA which can activate the innate immune system, leading to renal inflammation and apoptosis. Regulating proteins involved in these pathways may be an effective strategy to reduce renal tubular injury and alleviate AKI.
Mitochondrial dysfunction is increasingly considered as a critical contributor to the occurrence and progression of acute kidney injury (AKI). However, the mechanisms by which damaged mitochondria mediate AKI progression are multifactorial and complicated. Mitochondrial DNA (mtDNA) released from damaged mitochondria could serve as a danger-associated molecular pattern (DAMP) and activate the innate immune system through STING, TLR9, NLRP3, and some other adaptors, and further mediate tubular cell inflammation and apoptosis. Accumulating evidence has demonstrated the important role of circulating mtDNA and its related pathways in the progression of AKI, and regulating the proteins involved in these pathways may be an effective strategy to reduce renal tubular injury and alleviate AKI. Here, we aim to provide a comprehensive overview of recent studies on mtDNA-mediated renal pathological events to provide new insights in the setting of AKI.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available